Endoscopic aqueductoplasty

Area of Science:

• Neurosurgery
• Minimally Invasive Procedures
• Hydrocephalus Management

Background:

• Aqueductal stenosis can lead to hydrocephalus, often managed with shunts or endoscopic third ventriculostomy (ETV).
• Endoscopic aqueductoplasty (EA) presents an alternative surgical approach for specific cases of aqueductal stenosis.

Purpose of the Study:

• To evaluate the efficacy and outcomes of endoscopic aqueductoplasty (EA) as a treatment for aqueductal stenosis.
• To compare EA with or without stenting to ETV in selected patients.

Main Methods:

• A retrospective review of 45 patients with aqueductal stenosis who underwent EA between 2000 and 2005.
• Procedures included EA alone, EA with stenting, EA with ETV, and EA with stenting plus ETV.
• Success was defined as becoming shunt-free for noncommunicating hydrocephalus or not requiring a shunt for an isolated fourth ventricle.

Main Results:

• Out of 45 patients, 31 (69%) experienced positive outcomes from EA with or without stenting and/or ETV.
• Patient age, diagnosis, and specific endoscopic technique did not significantly impact the success rate.
• Fifteen patients were adults; various combinations of EA and ETV were performed.

Conclusions:

• Endoscopic aqueductoplasty with stenting is feasible for isolated fourth ventricle and challenging aqueduct stenosis cases where ETV is not suitable.
• EA alone or combined with ETV may be ineffective or even detrimental in some aqueduct stenosis cases.
• Long-term monitoring is essential to detect restenosis or stent migration years post-EA.